Journal article
Discovery of pyrido[3,4-g]quinazoline derivatives as CMGC family protein kinase inhibitors: Design, synthesis, inhibitory potency and X-ray co–crystal structure
- Abstract:
- The design and synthesis of new pyrido[3,4-g]quinazoline derivatives is described as well as their protein kinase inhibitory potencies towardfive CMGC family members (CDK5, CK1, GSK3, CLK1 and DYRK1A). The interest for this original tricyclic heteroaromatic scaffold as modulators of CLK1/ DYRK1A activity was validated by nanomolar potencies (compounds 12 and 13).CLK1 co-crystal structures with two inhibitors revealed the binding mode of these compounds within the ATPbinding pocket.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Accepted manuscript, pdf, 684.2KB)
-
- Publisher copy:
- 10.1016/j.ejmech.2016.04.004
Why is the content I wish to access not available via ORA?
Bibliographic data (the information relating to research outputs) and full-text items (e.g. articles, theses, reports, etc.) arrive in ORA from several different sources. Unfortunately we are not able to make available the full-text for every research output.
Please contact the ORA team (
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
Content may be unavailable for the following four reasons
-
Version unsuitable
-
We have not obtained a suitable full-text for a given research output. See this page for more information.
-
Recently completed
-
Sometimes content is held in ORA but is unavailable for a fixed period of time to comply with the policies and wishes of rights holders.
-
Permissions
-
All content made available in ORA should comply with relevant rights, such as copyright. See this page for more information.
-
Clearance
-
Some thesis volumes scanned as part of the digitisation scheme funded by Dr Leonard Polonsky are currently unavailable due to sensitive material or uncleared third-party copyright content. We are attempting to contact authors whose theses are affected.
Alternative access to the full-text
You may be able to access the full-text directly from the publisher's website using the 'Publisher Copy' link in the 'Links & Downloads' box from a research output's ORA record page. This method may require an institutional or individual subscription to the journal/resource.
Authors
Funding
The Auvergne Region
More from this funder
French Ministry of Higher Education and Research
More from this funder
Seventh Framework Programme
More from this funder
Fonds Unique Interministeriel
More from this funder
Fondation Jerome Lejeune
More from this funder
Bibliographic Details
- Publisher:
- Elsevier Publisher's website
- Journal:
- European Journal of Medicinal Chemistry Journal website
- Volume:
- 118
- Pages:
- 170-177
- Publication date:
- 2016-04-01
- Acceptance date:
- 2016-04-02
- DOI:
- Source identifiers:
-
624365
Item Description
- Keywords:
- Pubs id:
-
pubs:624365
- UUID:
-
uuid:39494b46-5603-44db-95ff-51679ee07206
- Local pid:
- pubs:624365
- Deposit date:
- 2016-05-27
Terms of use
- Copyright holder:
- Elsevier Masson SAS
- Copyright date:
- 2016
- Notes:
- © 2016 Elsevier Masson SAS. All rights reserved.
If you are the owner of this record, you can report an update to it here: Report update to this record